Oxazolidinones: A novel class of antibiotics

Cellular and Molecular Life Sciences

Volumn 56, Issue 3-4, 1999, Pages 280-285

  Muller M ^a   Schimz, K L ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

50S ribosomal subunits; Antibiotic eperezolid; Gram positive bacteria; Linezolid; Multidrug resistance; Oxazolidinone; Translation initiation

Indexed keywords

EPEREZOLID; FORMYLMETHIONINE; INITIATION FACTOR; LINEZOLID; N [[3 (4 ACETYLPHENYL) 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE; OXAZOLIDINONE DERIVATIVE; PEPTIDYLTRANSFERASE; TRANSFER RNA;

CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG ACTIVITY; DRUG BINDING SITE; DRUG MECHANISM; DRUG STRUCTURE; GRAM POSITIVE BACTERIUM; HUMAN; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; REVIEW; RIBOSOME SUBUNIT;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; OXAZOLIDINONES;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 0033569359     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050429     Document Type: Review

References (26)

1. Slee A. M., Wuonola M. A., McRipley R. J., Zajac I., Zawada M. J., Bartholomew P. T. et al. (1987) Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother. 31: 1791-1797
2. Ford C. W., Hamel J. C., Stapert D., Moerman J. K., Hutchinson D. K., Barbachyn M. R. et al. (1997) Ozazolidinones: new antibacterial agents. Trends Microbiol. 5: 196-200
3. Gadwood R. C., Walker E. A., Thomasco L. M., Barbachyn M. R., Grega K. C., Genin M. J. et al. (1998) Synthesis and antibacterial activity of azolyl-phenyl oxazolidinones having carbon-bound 1,3-thiazolyl rings. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
4. Genin M. J., Allwine D. A., Hutchinson D. K., Garmon S. A., Reischer R. J., Barbachyn M. R. et al. (1998) Substituent effects on the antibacterial activity of novel highly potent nitrogen-bound azolylpheriyl oxazolidinones. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
5. Hutchinson D. K., Barbachyn M. R., Hester J. B., Emmert D., Garmon S. A., Reischer R. J. et al. (1998) Synthesis and antibacterial activity of azolylphenyl-oxazolidinones having nitrogen-bound five-membered heterocyclic rings. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
6. Barbachyn M. R., Hutchinson D. K., Brickner S. J., Cynamon M. H., Kilburn J. O., Klemens S. P. et al. (1996) Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem. 39: 680-685
7. Dresser L. D. and Rybak M. J. (1998) The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacother. 18: 456-462
8. Eustice D. C., Feldman P. A. and Slee A. M. (1988) The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150: 965-971
9. Eustice D. C., Feldman P. A., Zajac I. and Slee A. M. (1988) Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32: 1218-1222
10. Burghardt H., Schimz K. L. and Müller M. (1998) On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant Gram-positive bacteria. FEBS Lett. 425: 40-44
11. Shinabarger D. L., Marotti K. R., Murray R. W., Lin A. H., Melchior E. P., Swaney S. M. et al. (1997) Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob. Agents Chemother. 41: 2132-2136
12. Swaney S. M., Aoki H., Canoza M. C. and Shinabarger D. L. (1998) The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob. Agents Chemother. 42: 3251-3255
13. Gualerzi C. O. and Pon C. L. (1990) Initiation of mRNA translation in prokaryotes. Biochem. 29: 5881-5889
14. Cundliffe E. (1980) Antibiotics and prokaryotic ribosomes: action, interaction and resistance. In: Ribosomes: Structure, Function and Genetics, pp. 555-581, Chambliss G. et al. (eds), University Park Press, Baltimore
15. Lin A. H., Murray R. W., Vidmar T. J. and Marotti K. R. (1997) The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother. 41: 2127- 2131
16. Murray R. W., Schaadt R. D., Zurenko G. E. and Marotti K. R. (1998) Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription translation assay. Antimicrob. Agents Chemother. 42: 947-950
17. Swaney S. M., Shinabarger D., Schaadt R., Bock J., Slightom J. and Zurenko G. (1998) Oxazolidinone resistance is associated with a mutation in the peptidyl transferase region of 23S rRNA. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
18. Zurenko G. E., Yagi B. H., Schaadt R. D., Allison J. W., Kilburn J. O., Glickman S. E. et al. (1996) In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40: 839-845
19. Yagi B. H. and Zurenko G. E. (1997) In vitro activity of linezolid and eperezolid, two novel oxazolidinone antimicrobial agents, against anaerobic bacteria. Anaerobe 3: 301-306
20. Goldstein E. J. C., Citron D. M., Gerardo S. H. and Merriam C. V. (1998) Linezolid compared with other macrolides against Pasteurella species. Abstract presented at the 38th Interscienee Conference on Antimicrobial Agents and Chemotherapy, San Diego
21. Wu M., Aralor P., Nash K., Bermudez L. E., Inderlied C. B. and Young L. S. (1998) Linezolid, a new oxazolidinone, has activity in vitro and in macrophage culture system against Mycobacterium avium complex (MAC). Abstract presented at the 38th Interscienee Conference on Antimicrobial Agents and Chemotherapy, San Diego
22. Birmingham M. C., Zimmer G. S., Hafkin B., Todd M., Batts D. H., Wilks N. E. et al. (1998) Initial results of linezolid in patients with multidrug-resistant gram-positive infections. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
23. Chiba K., Feenstra K. L., Slatter J. G., Daley-Yates P., Duncan J. N., Fagerness P. E. et al. (1998) Absorption, distribution, metabolism and excretion of the oxazolidinone antibiotic linezolid (PNU-100766) in the Sprague Dawley rat. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
24. Hyatt J. M., Ballow C. H., Forrest A., Turnak M. R., Stalker D. J., Welshman I. R. et al. (1998) Safely and efficacy of linezolid (PNU-100766) in eradication of nasal Staphylococcus aureus. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
25. Martin J. P., Herberg J. T., Slatter J. G. and Dupuis M. J. (1998) Although a novel microtiter-plate assay demonstrates that linezolid (PNU-100766) is a weak, competitive (reversible) inhibitor of human monoamine oxidase A (MAO A), no clinical evidence of MAO A inhibition in phase II or III clinical trials has been observed. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
26. Kaatz G. W. and Seo S. M. (1996) In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40: 799-801